ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

States Spent Only 3.2% Of Settlement Money On Smoking Cessation.

November 21, 2008

Funding Opportunities

October 25, 2002

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

More RFPs Coming On X-Ray imaging For Early Diagnosis, Including Sound

August 23, 1974

NCI Intends To Extend OSCC Two More Years

October 3, 1986

Cvitkovic Responds To Story On March ODAC Meeting.

June 23, 2000